Thomas J. Shaw Acquires 18,227 Shares of Retractable Technologies, Inc. (NYSE:RVP) Stock

Retractable Technologies, Inc. (NYSE:RVP) CEO Thomas J. Shaw acquired 18,227 shares of Retractable Technologies stock in a transaction dated Monday, February 3rd. The shares were acquired at an average cost of $0.77 per share, with a total value of $14,034.79. Following the completion of the acquisition, the chief executive officer now directly owns 15,037,535 shares in the company, valued at $11,578,901.95. This trade represents a 0.12 % increase in their position. The purchase was disclosed in a document filed with the SEC, which is accessible through this link.

Retractable Technologies Price Performance

Shares of NYSE:RVP opened at $0.79 on Friday. The company has a current ratio of 8.57, a quick ratio of 5.92 and a debt-to-equity ratio of 0.01. The business’s fifty day moving average price is $0.71 and its two-hundred day moving average price is $0.80. Retractable Technologies, Inc. has a fifty-two week low of $0.56 and a fifty-two week high of $1.34.

Institutional Investors Weigh In On Retractable Technologies

A hedge fund recently bought a new stake in Retractable Technologies stock. PFG Investments LLC acquired a new position in shares of Retractable Technologies, Inc. (NYSE:RVP) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 34,600 shares of the company’s stock, valued at approximately $27,000. PFG Investments LLC owned about 0.12% of Retractable Technologies at the end of the most recent quarter. Institutional investors and hedge funds own 7.58% of the company’s stock.

Wall Street Analyst Weigh In

Separately, StockNews.com began coverage on Retractable Technologies in a report on Friday. They set a “hold” rating on the stock.

About Retractable Technologies

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.